Angina Pectoris

Angina pectoris is a symptom of ischaemic heart disease, characterised by chest pain on exertion. Angina which occurs on exertion is known as stable angina.

Pathophysiology


Angina occurs due to a mismatch in the myocardial oxygen supply and demand. In normal physiology, if there is increased oxygen demand e.g. the heart is beating faster and therefore the tissues need more oxygen, the body is able to handle the increased need by increasing blood supply to the myocardium via the coronary arteries.

If, for example, there is stenosis (narrowing) of the coronary arteries from an atheromatous plaque, there may be sufficient blood flow to the heart tissue at rest. However, in this situation if the individual exerts themselves e.g. by going up the stairs, it is more difficult to get sufficient blood (and in turn oxygen) supply to the heart, manifesting in the symptoms of angina.

Causes


Angina can be provoked by various triggers including exertion, heavy meals, exposure to extreme temperatures and strong emotions. Underlying causes include coronary artery disease and anaemia. Coronary artery vasospasm can also cause pain at rest and is known as variant or Prinzmetal angina. It tends to affect women more than men.

Risk Factors


  • Smoking
  • Diabetes
  • Obesity
  • Sedentary lifestyle
  • Hypertension
  • History of coronary artery disease e.g. previous myocardial infarction

Clinical Features


There are 3 main symptoms to remember with angina:

  • Discomfort or pain in the chest, neck, shoulders, arms or jaw.
  • Triggered by physical exertion.
  • Relieved by rest or glyceryl trinitrate (GTN) within around 5 minutes.

These 3 symptoms are used to classify angina. 3/3 symptoms correlates to typical angina, 2/3 correlates to atypical angina and 1 of the symptoms should prompt consideration of an alternative diagnosis. Other symptoms include nausea, vomiting, dyspnoea and sweating. Continuous pain, pleuritic pain, palpitations, dizziness and tingling make a diagnosis of angina less likely.

Investigations


Diagnosis of angina is largely clinical, but they should be referred to a specialist chest pain service to confirm the diagnosis. Important investigations to consider include:

Bedside

  • 12-lead ECG to look for previous signs of cardiac ischaemia. These include:
    • Pathological Q waves
    • Left bundle branch block
    • ST-segment abnormalities
    • T-wave abnormalities

Bloods

  • FBC: Looking for an anaemia as a potential underlying cause
  • Serial troponins: If concerned about myocardial infarction
  • Lipid profile, HbA1c: High triglycerides would be a risk factor, as would co-existing T2DM.

Imaging

  • CXR: To consider alternative differentials for angina

Differential Diagnosis


Cardiac Causes of Chest Pain

  • Acute coronary syndrome
  • Aortic dissection
  • Pericarditis

Respiratory Causes of Chest Pain

  • Pneumothorax
  • Pleural effusion
  • Pulmonary embolism

Gastrointestinal Causes of Chest Pain

  • Oesophagitis
  • Rupture of oesophageal varices
  • GORD

Other Causes of Chest Pain

  • Costochondritis
  • Fibromyalgia
  • Anxiety

Management


There are a few things that need to be controlled in angina. These include the acute episodes of angina, secondary prevention of cardiovascular disease and prevention of further episodes of angina. The following summarises the NICE guidance on managing stable angina. Let’s consider each of these:

Acute Episodes

Treatment of anginal episodes is mainly with a short-acting nitrate e.g. a glyceryl trinitrate (GTN) spray. This is usually a sublingual spray administered under the tongue by the patient themselves. Patients should repeat the spray if pain does not subside within 5 minutes. If the pain is still present following the second dose, patients should be advised to call for an emergency ambulance.

Anti-Angina Treatment

NICE guidelines state that patients should be offered either one or two anti-anginal drugs (and drugs for secondary prevention of cardiovascular disease) for optimum drug treatment. The following summarises the NICE guidance for anti-angina treatment.

  1. A beta-blocker or calcium channel blocker (CCB) is offered as the first line treatment for stable angina. If patients cannot tolerate the beta-blocker or CCB, consider switching them to the other option e.g. if they’re on a CCB, swap to a beta-blocker.
     
  2. If symptoms remain uncontrolled on monotherapy, consider switching to the other option or using a combination of a beta-blocker and CCB. Non-dihydropyridine CCBs (such as verapamil or diltiazem) should not be given with beta-blockers due to risk of inducing a profound bradycardia secondary to complete heart block.
     
  3. If beta-blockers or CCBs are contraindicated or cannot be tolerated ONE of the following can be used instead:
    • Ivabradine
    • Nicorandil
    • Ranolazine
    • Long-acting nitrate e.g. isosorbide mononitrate: Patients on long-acting nitrates can develop tolerance to the nitrate very quickly i.e. they no longer achieve the same therapeutic benefit.

One of these drugs can also be added to a beta-blocker or CCB monotherapy regimen if symptoms remain uncontrolled, provided the patient cannot tolerate or has a contraindication to being given the other (beta-blocker/CCB) drug.
 

  1. Triple therapy is reserved for patients who have uncontrolled pain on two anti-anginal drugs and the individual is either awaiting revascularisation or revascularisation cannot be done.

Secondary Prevention of Cardiovascular Disease

NICE suggest considering 75mg aspirin OD, controlling hypertension and offering statin treatment in order to protect against further cardiovascular disease. Patients who are diabetic should be offered ACE inhibitors.

Revascularisation

Patients who still have ongoing symptoms despite optimal drug treatment can be considered for revascularisation therapy, either via a coronary artery bypass graft (CABG) or a percutaneous coronary intervention (PCI). A coronary angiogram is done prior to this in order to assess which treatment option would be most appropriate.

References


https://www.nice.org.uk/guidance/cg126/chapter/1-Guidance#general-principles-for-treating-people-with-stable-angina

https://cks.nice.org.uk/angina#!diagnosisSub:1

https://www.ncbi.nlm.nih.gov/books/NBK559016/

https://cvpharmacology.com/vasodilator/CCB

https://www.ncbi.nlm.nih.gov/books/NBK559016/

https://bnf.nice.org.uk/treatment-summary/calcium-channel-blockers.html